Fevipiprant, a selective prostaglandin D(2)receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by Tc2 cells (type-2 CD8(+)lymphocytes)

Παρόμοια τεκμήρια

• Fevipiprant, a selective prostaglandin D-2 receptor 2 antagonist, potently inhibits chemotaxis and cytokine production by group 2 innate lymphoid cells
  ανά: Xue, L, κ.ά.
  Έκδοση: (2018)
• Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
  ανά: Sandham, D, κ.ά.
  Έκδοση: (2019)
• Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s)
  ανά: Chen, W, κ.ά.
  Έκδοση: (2018)
• Fevipiprant, a selective prostaglandin D2 receptor 2 antagonist, inhibits human group 2 innate lymphoid cell aggregation and function
  ανά: Hardman, C, κ.ά.
  Έκδοση: (2019)
• Data on the oral CRTh2 antagonist QAW039 (fevipiprant) in patients with uncontrolled allergic asthma
  ανά: Veit J. Erpenbeck, κ.ά.
  Έκδοση: (2016-12-01)